Valid Ghana · FDA Ghana

BC GERMINA 2B SUSPENSION

Bacillus clausii Spores

FDA/SD.255-010173 Bacillus clausii Spores 4 Billion spores CFU

What it does

Bacillus is a type of bacteria that can be used in certain treatments to help with digestion and gut health.

Commonly used for: digestive issues, gastrointestinal disorders

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.255-010173
Registration date
2025-01-30
Expiry date
2030-02-01
Status
Valid
Active ingredient
Bacillus clausii Spores
Strength
4 Billion spores CFU
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Hi Tech Biosciences India
Country of origin
-
Manufacturer location
Plot No. 6 & 8, Survey No. 297+298 Ambadvet Industrial Estate, PO Paud, Tal, Mulshi, Ambarwet, Maharashtra 412115, India

Source: Food and Drugs Authority · fetched 2026-04-18 08:37:31 · updated 2026-09-25 04:00:09

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About bacillus

Bacillus is a type of bacteria that can be used in certain treatments to help with digestion and gut health.

What it treats

  • digestive issues
  • gastrointestinal disorders

How it works

Bacillus works by promoting good bacteria in the gut, helping to restore balance and improve digestion.

Who it's for

This treatment is suitable for individuals experiencing digestive problems or those looking to support their gut health.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About clausii

Clausii is a type of beneficial bacteria that helps maintain a healthy balance of gut flora.

What it treats

  • digestive issues
  • diarrhea
  • irritable bowel syndrome (IBS)

How it works

Clausii works by restoring the natural balance of good bacteria in the gut, which helps improve digestion and overall gut health.

Who it's for

Clausii is suitable for individuals experiencing digestive problems or looking to support their gut health.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About spores

Spores are a type of microscopic structure that can be used in various treatments.

What it treats

  • certain infections
  • immune system support

How it works

Spores can help the body fight off infections and support the immune system.

Who it's for

People who need treatment for specific infections or want to boost their immune health.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: bacillus

Bacillus Calmette-Guérin (BCG) is a live attenuated strain of Mycobacterium bovis, primarily used in immunotherapy for bladder cancer and as a vaccine against tuberculosis. BCG stimulates a cellular immune response, enhancing the body's ability to fight infections and malignancies. It is administered intravesically for bladder cancer and subcutaneously for tuberculosis vaccination.

Indications

  • Bladder cancer
  • Tuberculosis vaccination

Dosage

Children: Refer to the BNF for Children for appropriate dosing based on indication.

Adults: Refer to specific guidelines based on indication. For bladder cancer, a common regimen is instillation once a week for six weeks.

Mechanism of action

BCG works by stimulating the immune system, particularly through the activation of T-cells and macrophages. It enhances the immune response against tumor cells and Mycobacterium tuberculosis, promoting the release of cytokines and other immune mediators that contribute to the destruction of cancerous cells and pathogens.

Pharmacodynamics

The pharmacodynamics of BCG involve the induction of a robust immune response characterized by the activation of both innate and adaptive immunity. This includes the proliferation of T-lymphocytes and the production of cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukins, leading to increased immune surveillance and anti-tumor activity. The effectiveness of BCG is influenced by factors such as the host's immune status and the presence of any concurrent infections.

Pharmacokinetics

BCG is administered locally, and its pharmacokinetics are determined by the route of administration. After intravesical administration, BCG remains in the bladder and exerts its effects locally, with minimal systemic absorption. The half-life and clearance of BCG can vary based on the patient's immune response and presence of any concurrent conditions.

Interactions

  • normal immunoglobulin + bacillus calmette-gurin vaccine: Unknown (decreases efficacy)

Pregnancy

Bacillus Calmette-Guérin (BCG) vaccine can be administered during pregnancy if the potential benefit outweighs the potential risk.

Breast-feeding

BCG vaccine may be administered during breastfeeding; however, caution is advised.

Storage

Store at 2-8 degrees Celsius. Do not freeze.

Formulations

  • Bacillus Calmette-Guérin vaccine

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: clausii

Clausii, commonly known as Bacillus clausii, is a probiotic strain used to restore the balance of gut microbiota. It is particularly effective in managing gastrointestinal disorders and promoting overall digestive health. This strain is recognized for its ability to survive gastrointestinal transit and exert beneficial effects on the host's microbiome.

Indications

  • Diarrhea
  • Antibiotic-associated diarrhea
  • Irritable bowel syndrome
  • Gut dysbiosis
  • Prevention of gastrointestinal infections

Dosage

Children: Refer to specific product guidelines for paediatric dosing, as it may vary based on formulation.

Adults: Refer to specific product guidelines for adult dosing, as it may vary based on formulation.

Mechanism of action

Bacillus clausii exerts its effects primarily through the production of antimicrobial substances, which inhibit pathogenic bacteria and promote the growth of beneficial gut flora. It also enhances intestinal barrier function and modulates immune responses, contributing to the maintenance of gut homeostasis.

Pharmacodynamics

The pharmacodynamic profile of Bacillus clausii includes its ability to produce enzymes and metabolites that support digestion and nutrient absorption. It has been shown to reduce the duration and severity of diarrhea, particularly antibiotic-associated diarrhea, by restoring the gut microbiota balance. Additionally, it may enhance immune function, contributing to a lower incidence of gastrointestinal infections.

Pharmacokinetics

Bacillus clausii is characterized by its resilience to environmental stressors, allowing it to survive stomach acid and bile salts. After oral administration, it reaches the intestines where it colonizes and exerts its probiotic effects. The exact pharmacokinetics, including absorption and distribution, are not well-defined due to the nature of probiotics, but it is understood that its beneficial effects are mediated locally within the gastrointestinal tract.

Pregnancy

Clostridium butyricum (Clausii) is generally considered safe during pregnancy, but clinical data is limited. Consultation with a healthcare provider is recommended.

Breast-feeding

Clostridium butyricum (Clausii) is likely safe during breastfeeding, as it is a probiotic and generally well tolerated, but specific studies are lacking. Consultation with a healthcare provider is recommended.

Storage

Store in a cool, dry place. Refrigeration may be preferred to maintain potency.

Formulations

  • Capsules
  • Powder for oral suspension

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: spores

Spores are reproductive structures produced by certain bacteria, fungi, and plants, capable of developing into a new individual. They serve as a means of survival and dissemination, allowing organisms to withstand unfavorable environmental conditions. In the context of clinical use, spores can refer to bacterial spores, such as those from Bacillus species, which are of interest due to their potential in bioterrorism and certain infections. The study of spores also extends to their role in various biotechnological applications, including fermentation and as probiotics.

Indications

  • Bacterial infections
  • Probiotics
  • Biodefense
  • Food preservation
  • Fermentation processes

Dosage

Children: Paediatric dosing varies widely based on the condition being treated and the specific spore type. Refer to paediatric guidelines for

Adults: Dosage depends on the specific clinical context and the organism involved. Refer to appropriate clinical guidelines for specific dosing information.

Mechanism of action

Bacterial spores, such as those from Bacillus anthracis, can form endospores that are highly resistant to heat, desiccation, and chemical agents. Upon exposure to favorable conditions, these spores can germinate into vegetative cells, leading to infection. In contrast, fungal spores can germinate and develop into mycelium, contributing to the organism's growth and reproduction. The germination process involves the breakdown of the spore coat, hydration, and metabolic activation of the dormant spore.

Pharmacodynamics

The pharmacodynamics of spores largely depend on the type of spores and the context of their use. For instance, Bacillus spores can produce toxins that contribute to pathogenicity upon germination. In probiotics, certain spores are utilized for their beneficial effects on gut health, such as enhancing the immune response and outcompeting harmful bacteria. The effects can be dose-dependent and vary with the strain and formulation used.

Pharmacokinetics

Spores do not follow traditional pharmacokinetic profiles, as they are not absorbed or distributed in the body in the same way as conventional drugs. In the case of bacterial spores, their resistance to environmental stresses allows them to survive passage through the gastrointestinal tract. Upon reaching a suitable environment, they can germinate and produce active bacteria. For probiotic spores, the efficacy can be influenced by the formulation, including the presence of prebiotics and the delivery mechanism.

Pregnancy

The safety of spores during pregnancy is not well established. Caution is advised.

Breast-feeding

Data on the excretion of spores in breast milk is limited. Use with caution while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Ensure that the container is sealed tightly.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.